Biotechnology
The Biotechnology industry has a total of 677 stocks, with a combined market cap of $1,451.66 billion and total revenue of $121.81 billion.
Market Cap
1,451.66B
Revenue
121.81B
Profits
-33.53B
PE Ratio
n/a
Profit Margin
-27.53%
Dividend Yield
0.09%
677 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 572.04B | 1.31% | 3,709,397 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 112.90B | 2.08% | 1,057,719 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 106.01B | -0.65% | 590,217 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 49.46B | 0.58% | 2,938,518 | 5.15B |
| 5 | BNTX | BioNTech SE | 21.92B | -0.09% | 467,639 | 2.97B |
| 6 | ARGX | argenx SE | 21.39B | 5.88% | 343,792 | 39.48M |
| 7 | GMAB | Genmab A/S | 19.69B | 2.39% | 512,822 | 2.57B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.64B | -0.33% | 536,143 | 2.00B |
| 9 | BGNE | BeiGene, Ltd. | 17.97B | 2.56% | 130,609 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 15.27B | 0.94% | 2,068,301 | 2.47B |
| 11 | TECH | Bio-Techne Corporation | 13.16B | -0.77% | 1,149,194 | 1.15B |
| 12 | INCY | Incyte Corporation | 12.81B | - | 2,798,150 | 3.77B |
| 13 | RPRX | Royalty Pharma plc | 12.72B | 0.50% | 1,894,884 | 2.24B |
| 14 | SRPT | Sarepta Therapeutics, Inc. | 12.52B | -0.12% | 762,725 | 1.40B |
| 15 | UTHR | United Therapeutics Corporation | 12.10B | 1.08% | 320,500 | 2.50B |
| 16 | ROIV | Roivant Sciences Ltd. | 9.27B | 1.50% | 2,878,569 | 123.24M |
| 17 | VKTX | Viking Therapeutics, Inc. | 8.60B | 7.60% | 4,108,382 | - |
| 18 | LEGN | Legend Biotech Corporation | 8.32B | 3.11% | 1,043,790 | 342.80M |
| 19 | PCVX | Vaxcyte, Inc. | 7.79B | 6.39% | 673,307 | - |
| 20 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.71B | 0.17% | 1,144,741 | - |
| 21 | ASND | Ascendis Pharma A/S | 7.02B | -0.62% | 975,512 | 357.63M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 6.92B | -2.03% | 804,077 | 3.84B |
| 23 | BPMC | Blueprint Medicines Corporation | 6.69B | 1.26% | 758,088 | 282.21M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.50B | 5.38% | 1,326,003 | 4.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 6.34B | 1.92% | 1,230,919 | 3.75M |
| 26 | EXEL | Exelixis, Inc. | 6.15B | 0.62% | 1,745,983 | 1.85B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 5.83B | 4.56% | 1,233,053 | 862.99M |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 5.72B | 2.46% | 1,256,367 | 776.62M |
| 29 | BBIO | BridgeBio Pharma, Inc. | 5.61B | 3.52% | 1,409,091 | 218.60M |
| 30 | IBRX | ImmunityBio, Inc. | 5.48B | -3.57% | 4,436,119 | 302.00K |
| 31 | APLS | Apellis Pharmaceuticals, Inc. | 5.09B | 1.75% | 1,006,988 | 524.07M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.84B | 2.24% | 1,482,453 | 271.71M |
| 33 | KRYS | Krystal Biotech, Inc. | 4.66B | 2.33% | 270,718 | 95.95M |
| 34 | NUVL | Nuvalent, Inc. | 4.63B | 5.38% | 452,266 | - |
| 35 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.51B | 0.36% | 384,781 | - |
| 36 | IMVT | Immunovant, Inc. | 4.49B | 1.48% | 854,550 | - |
| 37 | ALPN | Alpine Immune Sciences, Inc. | 4.46B | 0.03% | 1,254,719 | 56.52M |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.98B | 2.25% | 990,888 | 1.97M |
| 39 | INSM | Insmed Incorporated | 3.70B | -2.04% | 1,828,935 | 315.49M |
| 40 | AXSM | Axsome Therapeutics, Inc. | 3.61B | -1.82% | 340,276 | 251.02M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.42B | 0.37% | 667,453 | 442.59M |
| 42 | SWTX | SpringWorks Therapeutics, Inc. | 3.35B | 5.24% | 603,978 | 26.45M |
| 43 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.24B | -0.43% | 894,053 | - |
| 44 | IDYA | IDEAYA Biosciences, Inc. | 3.21B | 1.53% | 751,252 | 15.50M |
| 45 | SMMT | Summit Therapeutics Inc. | 3.15B | -4.16% | 1,836,185 | - |
| 46 | APGE | Apogee Therapeutics, Inc. | 3.12B | -1.30% | 654,151 | - |
| 47 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.10B | 9.30% | 1,251,957 | 35.47M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 3.05B | -0.32% | 317,598 | - |
| 49 | IOVA | Iovance Biotherapeutics, Inc. | 2.99B | -0.37% | 6,992,053 | 1.90M |
| 50 | DNLI | Denali Therapeutics Inc. | 2.97B | 5.62% | 1,307,272 | 295.39M |
| 51 | CORT | Corcept Therapeutics Incorporated | 2.90B | 0.61% | 673,900 | 523.53M |
| 52 | FOLD | Amicus Therapeutics, Inc. | 2.86B | 3.54% | 2,703,671 | 423.49M |
| 53 | RNA | Avidity Biosciences, Inc. | 2.82B | 2.08% | 1,663,404 | 10.87M |
| 54 | IMCR | Immunocore Holdings plc | 2.80B | 0.29% | 708,451 | 264.25M |
| 55 | MOR | MorphoSys AG | 2.79B | 0.44% | 259,075 | 264.75M |
| 56 | ACLX | Arcellx, Inc. | 2.76B | 2.17% | 628,877 | 131.66M |
| 57 | TGTX | TG Therapeutics, Inc. | 2.74B | -1.34% | 3,315,661 | 289.33M |
| 58 | MRUS | Merus N.V. | 2.65B | 0.98% | 738,455 | 38.34M |
| 59 | CLDX | Celldex Therapeutics, Inc. | 2.65B | 1.77% | 462,549 | 6.07M |
| 60 | PTCT | PTC Therapeutics, Inc. | 2.58B | 7.95% | 573,640 | 927.56M |
| 61 | FTRE | Fortrea Holdings Inc. | 2.57B | -0.24% | 1,712,715 | 3.11B |
| 62 | MLTX | MoonLake Immunotherapeutics | 2.56B | -0.20% | 210,700 | - |
| 63 | NTLA | Intellia Therapeutics, Inc. | 2.53B | 1.90% | 1,272,411 | 52.60M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 2.50B | 1.75% | 2,330,526 | 813.81M |
| 65 | JANX | Janux Therapeutics, Inc. | 2.46B | -0.90% | 918,657 | 7.29M |
| 66 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.41B | -1.93% | 307,859 | 91.93M |
| 67 | VCEL | Vericel Corporation | 2.40B | 1.81% | 418,750 | 207.78M |
| 68 | DYN | Dyne Therapeutics, Inc. | 2.38B | 4.33% | 993,901 | - |
| 69 | VERA | Vera Therapeutics, Inc. | 2.34B | 4.45% | 426,487 | - |
| 70 | GERN | Geron Corporation | 2.31B | 5.98% | 6,970,815 | 520.00K |
| 71 | RXRX | Recursion Pharmaceuticals, Inc. | 2.30B | -0.40% | 6,829,455 | 46.24M |
| 72 | ARVN | Arvinas, Inc. | 2.21B | 3.09% | 697,290 | 71.30M |
| 73 | KYMR | Kymera Therapeutics, Inc. | 2.21B | 2.42% | 668,454 | 79.41M |
| 74 | RCKT | Rocket Pharmaceuticals, Inc. | 2.15B | 1.20% | 404,011 | - |
| 75 | ADMA | ADMA Biologics, Inc. | 2.11B | -0.66% | 3,087,100 | 283.18M |
| 76 | ZLAB | Zai Lab Limited | 2.06B | -3.25% | 618,390 | 291.07M |
| 77 | SANA | Sana Biotechnology, Inc. | 2.05B | 7.79% | 1,493,834 | - |
| 78 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 3.05% | 524,740 | 29.40M |
| 79 | BEAM | Beam Therapeutics Inc. | 1.98B | 1.26% | 777,828 | 360.91M |
| 80 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.97B | 1.03% | 1,161,143 | 411.35M |
| 81 | KROS | Keros Therapeutics, Inc. | 1.96B | 3.03% | 195,024 | 234.00K |
| 82 | GLPG | Galapagos NV | 1.92B | 1.57% | 68,154 | - |
| 83 | CGON | CG Oncology, Inc. | 1.87B | 2.53% | 907,245 | 539.00K |
| 84 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 1.29% | 620,620 | - |
| 85 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.86B | -2.75% | 66,215,882 | 208.70M |
| 86 | PTGX | Protagonist Therapeutics, Inc. | 1.85B | 6.28% | 676,117 | 314.95M |
| 87 | ARDX | Ardelyx, Inc. | 1.84B | 0.77% | 2,445,861 | 159.11M |
| 88 | FUSN | Fusion Pharmaceuticals Inc. | 1.83B | 0.51% | 474,522 | 2.04M |
| 89 | NVAX | Novavax, Inc. | 1.81B | -4.30% | 24,390,441 | 996.61M |
| 90 | INBX | Inhibrx, Inc. | 1.80B | 0.67% | 1,805,683 | 1.78M |
| 91 | NAMS | NewAmsterdam Pharma Company N.V. | 1.78B | -3.37% | 242,629 | - |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | -0.54% | 286,122 | 617.51M |
| 93 | GPCR | Structure Therapeutics Inc. | 1.68B | 1.04% | 643,008 | - |
| 94 | KURA | Kura Oncology, Inc. | 1.67B | 4.59% | 759,340 | - |
| 95 | EWTX | Edgewise Therapeutics, Inc. | 1.65B | 1.38% | 899,001 | - |
| 96 | SLNO | Soleno Therapeutics, Inc. | 1.65B | 3.93% | 161,692 | - |
| 97 | RCUS | Arcus Biosciences, Inc. | 1.60B | 2.57% | 859,346 | 237.00M |
| 98 | NMRA | Neumora Therapeutics, Inc. | 1.54B | 0.94% | 682,006 | - |
| 99 | LGND | Ligand Pharmaceuticals Incorporated | 1.54B | 0.56% | 164,730 | 118.31M |
| 100 | MORF | Morphic Holding, Inc. | 1.51B | 6.59% | 560,978 | - |
| 101 | SYRE | Spyre Therapeutics, Inc. | 1.51B | -4.86% | 299,258 | 688.00K |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | 4.67% | 1,616,674 | 274.10M |
| 103 | AKRO | Akero Therapeutics, Inc. | 1.46B | 3.79% | 500,535 | - |
| 104 | TARS | Tarsus Pharmaceuticals, Inc. | 1.45B | 1.34% | 367,342 | 42.56M |
| 105 | DAWN | Day One Biopharmaceuticals, Inc. | 1.43B | -1.20% | 571,311 | - |
| 106 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.43B | 3.18% | 244,756 | 301.77M |
| 107 | VIR | Vir Biotechnology, Inc. | 1.36B | -0.60% | 717,882 | 79.60M |
| 108 | GYRE | Gyre Therapeutics, Inc. | 1.34B | -0.76% | 57,044 | 140.62M |
| 109 | FDMT | 4D Molecular Therapeutics, Inc. | 1.32B | -0.66% | 429,968 | 20.45M |
| 110 | XNCR | Xencor, Inc. | 1.31B | 4.57% | 552,426 | 162.18M |
| 111 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.31B | 18.66% | 10,423,178 | 355.40M |
| 112 | BLTE | Belite Bio, Inc | 1.26B | 1.02% | 36,301 | - |
| 113 | MNKD | MannKind Corporation | 1.21B | -1.11% | 1,974,956 | 224.60M |
| 114 | PRTA | Prothena Corporation plc | 1.20B | 8.27% | 445,925 | 89.25M |
| 115 | MDXG | MiMedx Group, Inc. | 1.19B | 2.54% | 675,675 | 334.51M |
| 116 | PHVS | Pharvaris N.V. | 1.19B | 5.77% | 60,953 | - |
| 117 | MIRM | Mirum Pharmaceuticals, Inc. | 1.18B | 0.77% | 337,254 | 224.00M |
| 118 | CGEM | Cullinan Oncology, Inc. | 1.15B | 1.29% | 706,986 | - |
| 119 | IMTX | Immatics N.V. | 1.14B | -4.48% | 1,104,772 | 80.95M |
| 120 | VRNA | Verona Pharma plc | 1.13B | 0.50% | 325,431 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.13B | 0.54% | 394,296 | - |
| 122 | SRRK | Scholar Rock Holding Corporation | 1.12B | 0.21% | 950,538 | - |
| 123 | SAVA | Cassava Sciences, Inc. | 1.10B | -1.37% | 865,773 | - |
| 124 | ABCL | AbCellera Biologics Inc. | 1.09B | -3.14% | 1,023,579 | 35.79M |
| 125 | ARQT | Arcutis Biotherapeutics, Inc. | 1.07B | 13.65% | 13,876,757 | 106.39M |
| 126 | INVA | Innoviva, Inc. | 989.13M | -1.68% | 1,028,834 | 311.59M |
| 127 | SLN | Silence Therapeutics plc | 986.39M | 5.63% | 67,393 | 32.12M |
| 128 | OCUL | Ocular Therapeutix, Inc. | 974.25M | 3.97% | 3,668,896 | 59.84M |
| 129 | TYRA | Tyra Biosciences, Inc. | 967.63M | -0.75% | 129,116 | - |
| 130 | BCYC | Bicycle Therapeutics plc | 953.26M | 2.33% | 207,785 | 41.61M |
| 131 | NRIX | Nurix Therapeutics, Inc. | 943.15M | 6.35% | 979,079 | 80.89M |
| 132 | LQDA | Liquidia Corporation | 938.74M | 2.76% | 574,240 | 15.97M |
| 133 | PLRX | Pliant Therapeutics, Inc. | 926.60M | 8.63% | 1,259,822 | 248.00K |
| 134 | CNTA | Centessa Pharmaceuticals plc | 915.65M | -2.21% | 182,570 | 6.85M |
| 135 | VRDN | Viridian Therapeutics, Inc. | 910.75M | -2.73% | 708,608 | 288.00K |
| 136 | PROK | ProKidney Corp. | 910.31M | -4.85% | 1,432,145 | - |
| 137 | ETNB | 89bio, Inc. | 905.13M | 1.21% | 779,102 | - |
| 138 | RLAY | Relay Therapeutics, Inc. | 901.98M | 6.84% | 2,109,829 | 35.33M |
| 139 | IMNM | Immunome, Inc. | 887.16M | 0.54% | 930,286 | 12.68M |
| 140 | ABVX | Abivax SA | 877.70M | 1.08% | 171,556 | 5.13M |
| 141 | SPRY | ARS Pharmaceuticals, Inc. | 860.43M | -1.11% | 293,400 | 10.00K |
| 142 | ZNTL | Zentalis Pharmaceuticals, Inc. | 850.38M | 2.61% | 589,561 | 40.56M |
| 143 | TNGX | Tango Therapeutics, Inc. | 833.40M | 2.63% | 453,234 | 37.23M |
| 144 | CRGX | CARGO Therapeutics, Inc. | 826.35M | 6.55% | 164,233 | - |
| 145 | LBPH | Longboard Pharmaceuticals, Inc. | 821.92M | 3.88% | 186,657 | - |
| 146 | MESO | Mesoblast Limited | 821.69M | -0.42% | 76,338 | 7.25M |
| 147 | DNTH | Dianthus Therapeutics, Inc. | 812.69M | -0.89% | 113,767 | 2.26M |
| 148 | PRME | Prime Medicine, Inc. | 811.41M | 1.50% | 527,933 | 591.00K |
| 149 | RGNX | REGENXBIO Inc. | 799.42M | 2.72% | 390,854 | 86.73M |
| 150 | IRON | Disc Medicine, Inc. | 787.63M | 0.06% | 363,455 | - |
| 151 | ARCT | Arcturus Therapeutics Holdings Inc. | 781.43M | -2.44% | 293,131 | 124.53M |
| 152 | PRTC | PureTech Health plc | 770.95M | 1.79% | 1,589 | 3.33M |
| 153 | HUMA | Humacyte, Inc. | 770.47M | 0.78% | 4,583,586 | - |
| 154 | AUPH | Aurinia Pharmaceuticals Inc. | 759.43M | 2.12% | 1,756,242 | 191.41M |
| 155 | ALXO | ALX Oncology Holdings Inc. | 758.49M | -0.99% | 315,837 | - |
| 156 | PRAX | Praxis Precision Medicines, Inc. | 752.74M | -4.14% | 701,188 | 2.20M |
| 157 | HLVX | HilleVax, Inc. | 750.79M | 15.00% | 569,170 | - |
| 158 | COGT | Cogent Biosciences, Inc. | 738.14M | 5.03% | 621,469 | - |
| 159 | STOK | Stoke Therapeutics, Inc. | 736.45M | 10.39% | 1,238,657 | 7.85M |
| 160 | WVE | Wave Life Sciences Ltd. | 722.51M | 1.03% | 432,724 | 112.91M |
| 161 | NUVB | Nuvation Bio Inc. | 719.55M | - | 2,973,723 | - |
| 162 | CVAC | CureVac N.V. | 714.19M | 2.90% | 513,401 | 59.73M |
| 163 | SAGE | Sage Therapeutics, Inc. | 704.73M | -2.34% | 919,864 | 91.06M |
| 164 | ANAB | AnaptysBio, Inc. | 699.36M | 1.35% | 212,943 | 22.96M |
| 165 | KYTX | Kyverna Therapeutics, Inc. | 684.24M | 2.39% | 496,375 | - |
| 166 | AUTL | Autolus Therapeutics plc | 684.22M | - | 974,267 | 1.70M |
| 167 | EYPT | EyePoint Pharmaceuticals, Inc. | 673.97M | 3.94% | 978,073 | 50.02M |
| 168 | SVRA | Savara Inc. | 667.45M | 0.42% | 669,287 | - |
| 169 | LYEL | Lyell Immunopharma, Inc. | 665.39M | 2.76% | 493,040 | 68.00K |
| 170 | GHRS | GH Research PLC | 662.84M | -2.15% | 19,185 | - |
| 171 | AVBP | ArriVent BioPharma, Inc. | 653.13M | 5.63% | 50,635 | - |
| 172 | MLYS | Mineralys Therapeutics, Inc. | 648.91M | 0.08% | 74,821 | - |
| 173 | ZYME | Zymeworks Inc. | 646.95M | 1.67% | 494,388 | 50.46M |
| 174 | ITOS | iTeos Therapeutics, Inc. | 645.94M | 7.42% | 556,158 | - |
| 175 | PHAR | Pharming Group N.V. | 645.49M | 2.19% | 1,816 | 280.83M |
| 176 | EXAI | Exscientia plc | 644.85M | 2.81% | 627,711 | 25.42M |
| 177 | MNMD | Mind Medicine (MindMed) Inc. | 639.44M | 6.83% | 1,351,707 | - |
| 178 | ALT | Altimmune, Inc. | 628.84M | 13.43% | 3,992,223 | 410.00K |
| 179 | ORIC | ORIC Pharmaceuticals, Inc. | 627.70M | 2.42% | 421,915 | - |
| 180 | VALN | Valneva SE | 615.75M | 10.24% | 46,058 | 166.26M |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 609.24M | 0.19% | 329,627 | 2.59M |
| 182 | AVTE | Aerovate Therapeutics, Inc. | 603.77M | 8.97% | 332,887 | - |
| 183 | ENGN | enGene Holdings Inc. | 600.65M | -4.14% | 6,372 | - |
| 184 | CALT | Calliditas Therapeutics AB (publ) | 594.06M | -0.47% | 1,651 | 119.73M |
| 185 | CABA | Cabaletta Bio, Inc. | 593.95M | 13.00% | 1,087,551 | - |
| 186 | CDMO | Avid Bioservices, Inc. | 587.19M | 0.54% | 1,330,940 | 136.74M |
| 187 | TSHA | Taysha Gene Therapies, Inc. | 581.63M | 21.01% | 4,675,808 | 14.16M |
| 188 | ADPT | Adaptive Biotechnologies Corporation | 574.74M | -1.52% | 1,412,628 | 174.50M |
| 189 | IGMS | IGM Biosciences, Inc. | 560.13M | 3.15% | 373,321 | 2.11M |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 550.95M | -3.15% | 1,633,629 | - |
| 191 | ABSI | Absci Corporation | 545.63M | -0.10% | 588,087 | 5.35M |
| 192 | ALEC | Alector, Inc. | 544.57M | 6.00% | 487,204 | 96.41M |
| 193 | YMAB | Y-mAbs Therapeutics, Inc. | 534.49M | 3.05% | 263,697 | 84.50M |
| 194 | OABI | OmniAb, Inc. | 533.97M | 0.89% | 424,197 | 21.05M |
| 195 | ABUS | Arbutus Biopharma Corporation | 530.29M | -1.75% | 426,514 | 12.99M |
| 196 | THRD | Third Harmonic Bio, Inc. | 526.58M | 0.08% | 94,318 | - |
| 197 | CELC | Celcuity Inc. | 524.71M | 2.01% | 107,847 | - |
| 198 | TVTX | Travere Therapeutics, Inc. | 517.68M | 1.49% | 1,027,602 | 183.23M |
| 199 | CBUS | Cibus, Inc. | 513.85M | -1.53% | 39,476 | 2.32M |
| 200 | FULC | Fulcrum Therapeutics, Inc. | 512.77M | 4.30% | 1,029,468 | 2.51M |
| 201 | ATXS | Astria Therapeutics, Inc. | 509.04M | -2.32% | 625,272 | - |
| 202 | ALLO | Allogene Therapeutics, Inc. | 508.75M | 0.68% | 3,454,928 | 65.00K |
| 203 | KALV | KalVista Pharmaceuticals, Inc. | 506.68M | -3.84% | 265,553 | - |
| 204 | OCGN | Ocugen, Inc. | 504.36M | 15.29% | 15,541,129 | 7.05M |
| 205 | APLT | Applied Therapeutics, Inc. | 502.77M | -5.17% | 984,083 | -477.00K |
| 206 | LRMR | Larimar Therapeutics, Inc. | 502.11M | -0.13% | 163,405 | - |
| 207 | URGN | UroGen Pharma Ltd. | 497.87M | 6.25% | 613,590 | 84.30M |
| 208 | EDIT | Editas Medicine, Inc. | 493.43M | 5.63% | 2,439,586 | 69.41M |
| 209 | VERV | Verve Therapeutics, Inc. | 489.36M | - | 1,152,351 | 16.05M |
| 210 | TRDA | Entrada Therapeutics, Inc. | 489.17M | 2.11% | 43,158 | 162.87M |
| 211 | NKTX | Nkarta, Inc. | 484.82M | 5.04% | 550,992 | - |
| 212 | FATE | Fate Therapeutics, Inc. | 482.65M | 0.47% | 1,816,838 | 6.48M |
| 213 | LXRX | Lexicon Pharmaceuticals, Inc. | 477.70M | 1.04% | 1,451,043 | 2.31M |
| 214 | BMEA | Biomea Fusion, Inc. | 475.91M | 7.03% | 929,565 | - |
| 215 | TBPH | Theravance Biopharma, Inc. | 474.42M | 4.90% | 270,265 | 57.42M |
| 216 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 471.71M | 2.68% | 251,238 | - |
| 217 | VYGR | Voyager Therapeutics, Inc. | 466.11M | 1.06% | 499,086 | 119.04M |
| 218 | SLRN | Acelyrin, Inc. | 461.39M | 0.21% | 458,129 | - |
| 219 | LXEO | Lexeo Therapeutics, Inc. | 459.95M | -0.07% | 77,129 | - |
| 220 | HRTX | Heron Therapeutics, Inc. | 451.96M | 6.76% | 2,140,058 | 132.10M |
| 221 | PEPG | PepGen Inc. | 447.64M | -1.22% | 39,729 | - |
| 222 | RNAC | Cartesian Therapeutics, Inc. | 447.22M | 7.68% | 123,097 | 25.91M |
| 223 | OCS | Oculis Holding AG | 441.25M | -1.23% | 2,936 | 995.46K |
| 224 | NGNE | Neurogene Inc. | 436.01M | 6.72% | 50,992 | - |
| 225 | MREO | Mereo BioPharma Group plc | 428.08M | 7.09% | 546,347 | 10.00M |
| 226 | KRRO | Korro Bio, Inc. | 423.39M | 5.43% | 34,549 | - |
| 227 | CCCC | C4 Therapeutics, Inc. | 420.40M | 1.83% | 2,085,823 | 20.04M |
| 228 | REPL | Replimune Group, Inc. | 418.05M | 1.49% | 547,785 | - |
| 229 | TCRX | TScan Therapeutics, Inc. | 411.68M | -0.67% | 346,939 | 14.81M |
| 230 | CADL | Candel Therapeutics, Inc. | 410.87M | 30.84% | 1,679,658 | - |
| 231 | ANNX | Annexon, Inc. | 410.14M | -6.64% | 2,951,273 | - |
| 232 | LENZ | LENZ Therapeutics, Inc. | 404.45M | 0.76% | 97,471 | - |
| 233 | ADCT | ADC Therapeutics SA | 397.41M | 2.23% | 455,747 | 68.62M |
| 234 | TRML | Tourmaline Bio, Inc. | 391.11M | 5.76% | 177,045 | - |
| 235 | STTK | Shattuck Labs, Inc. | 388.02M | -3.77% | 577,612 | 2.72M |
| 236 | TERN | Terns Pharmaceuticals, Inc. | 387.40M | - | 905,578 | - |
| 237 | VRCA | Verrica Pharmaceuticals Inc. | 386.02M | -4.11% | 267,289 | 8.91M |
| 238 | CTNM | Contineum Therapeutics, Inc. | 385.25M | -0.97% | 28,214 | 50.00M |
| 239 | AVXL | Anavex Life Sciences Corp. | 380.04M | 4.18% | 1,464,266 | - |
| 240 | FBLG | FibroBiologics, Inc. | 375.94M | 1.68% | 71,025 | - |
| 241 | ANRO | Alto Neuroscience, Inc. | 372.07M | -2.26% | 121,223 | - |
| 242 | AURA | Aura Biosciences, Inc. | 371.50M | -0.40% | 199,765 | - |
| 243 | SLDB | Solid Biosciences Inc. | 366.87M | -2.71% | 68,026 | - |
| 244 | PGEN | Precigen, Inc. | 363.48M | 5.11% | 712,234 | 5.44M |
| 245 | NAUT | Nautilus Biotechnology, Inc. | 359.51M | 0.35% | 139,045 | - |
| 246 | SKYE | Skye Bioscience, Inc. | 355.84M | 4.28% | 54,687 | - |
| 247 | MGTX | MeiraGTx Holdings plc | 355.62M | 5.74% | 158,423 | 697.00K |
| 248 | QTTB | Q32 Bio Inc. | 351.10M | 4.29% | 29,751 | 354.00K |
| 249 | ACIU | AC Immune SA | 348.18M | -1.96% | 1,003,102 | 16.82M |
| 250 | RVNC | Revance Therapeutics, Inc. | 345.72M | -4.89% | 2,355,161 | 236.65M |
| 251 | NBTX | Nanobiotix S.A. | 344.38M | 2.88% | 1,618 | 40.23M |
| 252 | ATAI | Atai Life Sciences N.V. | 343.20M | 7.33% | 1,651,009 | 314.00K |
| 253 | GUTS | Fractyl Health, Inc. | 342.33M | 8.01% | 194,255 | 148.00K |
| 254 | INO | Inovio Pharmaceuticals, Inc. | 338.60M | 14.45% | 731,542 | 717.07K |
| 255 | NKTR | Nektar Therapeutics | 336.03M | 3.39% | 1,346,276 | 90.17M |
| 256 | PSTX | Poseida Therapeutics, Inc. | 335.37M | 18.49% | 1,230,739 | 82.50M |
| 257 | IMMP | Immutep Limited | 335.25M | -3.58% | 260,887 | 4.58M |
| 258 | TNYA | Tenaya Therapeutics, Inc. | 333.70M | -3.41% | 329,884 | - |
| 259 | VSTM | Verastem, Inc. | 332.27M | -0.30% | 147,353 | - |
| 260 | CRBU | Caribou Biosciences, Inc. | 328.76M | - | 2,467,232 | 33.40M |
| 261 | ERAS | Erasca, Inc. | 327.65M | 1.61% | 411,590 | - |
| 262 | JSPR | Jasper Therapeutics, Inc. | 325.85M | 3.25% | 101,005 | - |
| 263 | STRO | Sutro Biopharma, Inc. | 321.34M | -9.45% | 571,801 | 154.07M |
| 264 | MRSN | Mersana Therapeutics, Inc. | 314.47M | -1.53% | 1,861,622 | 38.30M |
| 265 | AVIR | Atea Pharmaceuticals, Inc. | 312.47M | -6.31% | 723,087 | - |
| 266 | VNDA | Vanda Pharmaceuticals Inc. | 311.94M | 4.48% | 903,507 | 177.60M |
| 267 | BDTX | Black Diamond Therapeutics, Inc. | 306.02M | -5.23% | 2,519,461 | - |
| 268 | VTYX | Ventyx Biosciences, Inc. | 295.39M | 0.48% | 431,823 | - |
| 269 | MGNX | MacroGenics, Inc. | 294.66M | 5.84% | 3,540,933 | 43.36M |
| 270 | XERS | Xeris Biopharma Holdings, Inc. | 293.55M | 4.21% | 1,809,575 | 171.36M |
| 271 | IVVD | Invivyd, Inc. | 293.28M | 1.23% | 451,340 | - |
| 272 | ATNM | Actinium Pharmaceuticals, Inc. | 289.79M | -1.62% | 370,330 | 81.00K |
| 273 | INZY | Inozyme Pharma, Inc. | 288.87M | 0.86% | 341,685 | - |
| 274 | CRMD | CorMedix Inc. | 288.54M | -1.50% | 504,344 | - |
| 275 | XOMA | XOMA Corporation | 287.27M | -3.44% | 11,658 | 5.81M |
| 276 | OPT | Opthea Limited | 282.89M | -2.76% | 24,567 | 385.28K |
| 277 | ENTA | Enanta Pharmaceuticals, Inc. | 282.53M | 0.76% | 72,278 | 72.88M |
| 278 | ADAP | Adaptimmune Therapeutics plc | 281.69M | 7.83% | 1,417,397 | 60.28M |
| 279 | RANI | Rani Therapeutics Holdings, Inc. | 278.79M | -2.42% | 210,336 | - |
| 280 | CYBN | Cybin Inc. | 277.07M | 2.40% | 2,780,347 | - |
| 281 | EPIX | ESSA Pharma Inc. | 274.28M | 4.00% | 57,294 | - |
| 282 | CDXC | ChromaDex Corporation | 274.21M | -0.82% | 173,816 | 83.17M |
| 283 | ACRV | Acrivon Therapeutics, Inc. | 267.07M | 3.47% | 37,923 | - |
| 284 | GLUE | Monte Rosa Therapeutics, Inc. | 264.18M | 4.60% | 123,618 | 1.06M |
| 285 | QSI | Quantum-Si incorporated | 263.78M | 1.64% | 456,688 | 1.29M |
| 286 | XBIT | XBiotech Inc. | 261.63M | -2.50% | 56,020 | - |
| 287 | CDXS | Codexis, Inc. | 261.06M | 1.37% | 398,558 | 74.23M |
| 288 | IPSC | Century Therapeutics, Inc. | 256.00M | -1.90% | 69,151 | 1.37M |
| 289 | MGX | Metagenomi, Inc. | 254.81M | 3.98% | 65,081 | 47.26M |
| 290 | DSGN | Design Therapeutics, Inc. | 254.79M | 0.45% | 112,878 | - |
| 291 | GBIO | Generation Bio Co. | 251.99M | 7.06% | 287,102 | 9.96M |
| 292 | TSVT | 2seventy bio, Inc. | 250.34M | 2.96% | 288,912 | 71.20M |
| 293 | CHRS | Coherus BioSciences, Inc. | 250.10M | 4.81% | 2,470,761 | 301.87M |
| 294 | PYXS | Pyxis Oncology, Inc. | 247.87M | 0.24% | 363,347 | 16.15M |
| 295 | ALDX | Aldeyra Therapeutics, Inc. | 247.76M | - | 379,281 | - |
| 296 | AKBA | Akebia Therapeutics, Inc. | 247.32M | -4.07% | 3,540,675 | 187.23M |
| 297 | QURE | uniQure N.V. | 245.66M | 3.05% | 462,888 | 19.00M |
| 298 | GTHX | G1 Therapeutics, Inc. | 245.20M | 0.86% | 481,524 | 84.04M |
| 299 | ANL | Adlai Nortye Ltd. | 241.90M | 1.74% | 6,980 | 5.00M |
| 300 | OMER | Omeros Corporation | 241.63M | -0.71% | 451,209 | - |
| 301 | OVID | Ovid Therapeutics Inc. | 235.09M | 2.79% | 153,008 | 473.54K |
| 302 | ABOS | Acumen Pharmaceuticals, Inc. | 228.30M | 2.98% | 213,698 | - |
| 303 | AGEN | Agenus Inc. | 226.37M | 0.75% | 354,944 | 161.42M |
| 304 | ZURA | Zura Bio Limited | 226.25M | 0.58% | 128,198 | - |
| 305 | FHTX | Foghorn Therapeutics Inc. | 225.28M | -6.70% | 78,494 | 33.90M |
| 306 | INMB | INmune Bio, Inc. | 224.48M | 8.29% | 138,421 | 131.00K |
| 307 | PBYI | Puma Biotechnology, Inc. | 224.31M | -5.87% | 457,546 | 226.63M |
| 308 | ELYM | Eliem Therapeutics, Inc. | 221.51M | -2.44% | 202,658 | - |
| 309 | MACK | Merrimack Pharmaceuticals, Inc. | 219.87M | 0.07% | 372,579 | - |
| 310 | PRLD | Prelude Therapeutics Incorporated | 219.72M | 3.63% | 47,551 | - |
| 311 | CLLS | Cellectis S.A. | 219.56M | -1.97% | 11,041 | 9.19M |
| 312 | CDT | Conduit Pharmaceuticals Inc. | 219.27M | 4.93% | 12,511 | - |
| 313 | VERU | Veru Inc. | 215.18M | - | 1,424,894 | 13.48M |
| 314 | BOLD | Boundless Bio, Inc. | 211.94M | 3.02% | 109,636 | - |
| 315 | CMPX | Compass Therapeutics, Inc. | 211.89M | -4.64% | 680,700 | - |
| 316 | HOWL | Werewolf Therapeutics, Inc. | 210.76M | -1.62% | 160,873 | 16.22M |
| 317 | BLUE | bluebird bio, Inc. | 206.23M | - | 3,030,439 | 21.73M |
| 318 | LCTX | Lineage Cell Therapeutics, Inc. | 205.79M | 4.81% | 975,487 | 8.00M |
| 319 | CRVO | CervoMed Inc. | 204.03M | 0.08% | 23,705 | 6.36M |
| 320 | ELEV | Elevation Oncology, Inc. | 203.80M | 4.78% | 258,139 | - |
| 321 | IPHA | Innate Pharma S.A. | 202.61M | 0.04% | 8,807 | 68.49M |
| 322 | ATOS | Atossa Therapeutics, Inc. | 201.74M | 4.55% | 1,208,155 | - |
| 323 | ZVRA | Zevra Therapeutics, Inc. | 201.73M | 0.42% | 157,679 | 28.01M |
| 324 | CGEN | Compugen Ltd. | 197.86M | 5.74% | 312,724 | 33.46M |
| 325 | KOD | Kodiak Sciences Inc. | 196.44M | -2.60% | 346,849 | - |
| 326 | IVA | Inventiva S.A. | 195.87M | 2.47% | 11,585 | 25.74M |
| 327 | TRVI | Trevi Therapeutics, Inc. | 194.75M | -5.31% | 221,781 | - |
| 328 | TELO | Telomir Pharmaceuticals, Inc. | 194.23M | -2.51% | 7,964 | - |
| 329 | YS | YS Biopharma Co., Ltd. | 193.98M | 2.72% | 72,226 | - |
| 330 | GLSI | Greenwich LifeSciences, Inc. | 189.96M | 8.14% | 24,201 | - |
| 331 | GALT | Galectin Therapeutics Inc. | 189.43M | 7.75% | 136,424 | - |
| 332 | FENC | Fennec Pharmaceuticals Inc. | 189.16M | -4.90% | 779,300 | 44.95M |
| 333 | GNFT | Genfit S.A. | 188.31M | 2.71% | 3,153 | 42.42M |
| 334 | ABEO | Abeona Therapeutics Inc. | 186.70M | 12.14% | 1,101,321 | 3.50M |
| 335 | DRTS | Alpha Tau Medical Ltd. | 184.63M | -0.75% | 15,888 | - |
| 336 | ADVM | Adverum Biotechnologies, Inc. | 181.62M | -2.02% | 250,249 | - |
| 337 | ACHV | Achieve Life Sciences, Inc. | 178.92M | 3.79% | 233,511 | - |
| 338 | OTLK | Outlook Therapeutics, Inc. | 173.11M | 0.41% | 224,513 | - |
| 339 | OBIO | Orchestra BioMed Holdings, Inc. | 172.13M | -7.50% | 31,237 | 2.22M |
| 340 | RIGL | Rigel Pharmaceuticals, Inc. | 170.04M | 2.31% | 602,447 | 120.35M |
| 341 | MDWD | MediWound Ltd. | 169.33M | 0.22% | 61,716 | 18.69M |
| 342 | CAPR | Capricor Therapeutics, Inc. | 167.91M | 2.50% | 284,192 | 27.10M |
| 343 | GOSS | Gossamer Bio, Inc. | 167.90M | 1.28% | 1,983,641 | - |
| 344 | VXRT | Vaxart, Inc. | 167.04M | 9.24% | 2,109,079 | 8.89M |
| 345 | SCPH | scPharmaceuticals Inc. | 164.77M | 1.56% | 828,282 | 17.63M |
| 346 | XFOR | X4 Pharmaceuticals, Inc. | 163.94M | -0.93% | 1,158,461 | - |
| 347 | CRDF | Cardiff Oncology, Inc. | 159.67M | -0.28% | 329,189 | 610.00K |
| 348 | TVGN | Tevogen Bio Holdings Inc. | 159.59M | 5.38% | 651,489 | - |
| 349 | PRQR | ProQR Therapeutics N.V. | 154.36M | -3.78% | 120,660 | 14.66M |
| 350 | CTMX | CytomX Therapeutics, Inc. | 152.72M | 1.03% | 3,706,847 | 119.18M |
| 351 | RENB | Renovaro Biosciences Inc. | 151.80M | -8.91% | 236,818 | - |
| 352 | RPTX | Repare Therapeutics Inc. | 151.53M | -3.25% | 182,003 | 97.86M |
| 353 | RAPT | RAPT Therapeutics, Inc. | 148.17M | 6.13% | 1,201,738 | - |
| 354 | SGMT | Sagimet Biosciences Inc. | 147.44M | 5.48% | 409,329 | 2.00M |
| 355 | SYRS | Syros Pharmaceuticals, Inc. | 147.27M | 1.47% | 169,240 | 6.98M |
| 356 | MCRB | Seres Therapeutics, Inc. | 145.07M | 6.92% | 3,530,293 | 126.85M |
| 357 | BCAB | BioAtla, Inc. | 144.32M | 14.94% | 1,313,782 | - |
| 358 | IMAB | I-Mab | 140.18M | -1.62% | 156,099 | 3.90M |
| 359 | SEER | Seer, Inc. | 138.96M | -0.93% | 325,477 | 15.67M |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 138.86M | -1.77% | 234,379 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 133.01M | 3.67% | 1,841,958 | 140.46M |
| 362 | RGLS | Regulus Therapeutics Inc. | 132.24M | -2.88% | 605,491 | - |
| 363 | LIFE | aTyr Pharma, Inc. | 132.16M | 5.22% | 487,606 | 588.00K |
| 364 | VIGL | Vigil Neuroscience, Inc. | 130.98M | -4.78% | 52,738 | - |
| 365 | DBVT | DBV Technologies S.A. | 130.08M | -2.32% | 101,531 | 14.94M |
| 366 | PDSB | PDS Biotechnology Corporation | 128.38M | -0.99% | 582,327 | - |
| 367 | CNTX | Context Therapeutics Inc. | 126.75M | 0.58% | 231,623 | - |
| 368 | OMGA | Omega Therapeutics, Inc. | 125.75M | -3.39% | 414,011 | 4.94M |
| 369 | VTGN | VistaGen Therapeutics, Inc. | 124.05M | 1.55% | 101,212 | 1.04M |
| 370 | AMLX | Amylyx Pharmaceuticals, Inc. | 123.77M | -2.67% | 1,087,360 | 398.00M |
| 371 | MOLN | Molecular Partners AG | 123.11M | 3.92% | 1,730 | 8.38M |
| 372 | COYA | Coya Therapeutics, Inc. | 122.79M | 2.06% | 29,849 | 6.13M |
| 373 | NVCT | Nuvectis Pharma, Inc. | 122.07M | 0.15% | 124,752 | - |
| 374 | CLRB | Cellectar Biosciences, Inc. | 120.45M | 5.03% | 1,107,223 | - |
| 375 | SGMO | Sangamo Therapeutics, Inc. | 120.37M | 2.15% | 1,910,151 | 18.76M |
| 376 | VOR | Vor Biopharma Inc. | 118.70M | 3.57% | 188,754 | - |
| 377 | FGEN | FibroGen, Inc. | 118.38M | 0.85% | 1,743,313 | 167.49M |
| 378 | ADAG | Adagene Inc. | 117.33M | - | 16,640 | 18.11M |
| 379 | IMUX | Immunic, Inc. | 116.65M | 1.17% | 137,150 | - |
| 380 | ACET | Adicet Bio, Inc. | 115.04M | 5.26% | 2,663,004 | - |
| 381 | DMAC | DiaMedica Therapeutics Inc. | 114.27M | 0.99% | 12,188 | - |
| 382 | CTXR | Citius Pharmaceuticals, Inc. | 112.77M | -9.15% | 2,437,351 | - |
| 383 | PMVP | PMV Pharmaceuticals, Inc. | 111.12M | 0.93% | 397,239 | - |
| 384 | BYSI | BeyondSpring Inc. | 110.41M | 5.99% | 51,713 | 1.75M |
| 385 | LPTX | Leap Therapeutics, Inc. | 107.14M | -0.36% | 298,430 | - |
| 386 | ELTX | Elicio Therapeutics, Inc. | 106.41M | 0.97% | 45,099 | - |
| 387 | RZLT | Rezolute, Inc. | 106.34M | -1.12% | 148,727 | - |
| 388 | VANI | Vivani Medical, Inc. | 105.01M | 4.37% | 208,629 | - |
| 389 | RLMD | Relmada Therapeutics, Inc. | 105.01M | -4.40% | 67,438 | - |
| 390 | ALLK | Allakos Inc. | 104.93M | -0.42% | 280,855 | - |
| 391 | CNTB | Connect Biopharma Holdings Limited | 100.29M | -4.12% | 118,508 | - |
| 392 | CLSD | Clearside Biomedical, Inc. | 98.65M | 3.13% | 151,234 | 8.45M |
| 393 | GNLX | Genelux Corporation | 97.79M | 1.68% | 89,026 | 8.00K |
| 394 | ANVS | Annovis Bio, Inc. | 97.42M | 4.31% | 1,013,467 | - |
| 395 | ORMP | Oramed Pharmaceuticals Inc. | 97.10M | -3.24% | 122,939 | 674.00K |
| 396 | ARMP | Armata Pharmaceuticals, Inc. | 95.81M | -7.19% | 25,241 | 4.70M |
| 397 | IOBT | IO Biotech, Inc. | 94.21M | -0.69% | 118,985 | - |
| 398 | ANIX | Anixa Biosciences, Inc. | 93.47M | -1.68% | 50,633 | 210.00K |
| 399 | ENTX | Entera Bio Ltd. | 92.96M | 4.38% | 199,363 | - |
| 400 | MIST | Milestone Pharmaceuticals Inc. | 91.95M | 0.29% | 49,303 | - |
| 401 | CMRX | Chimerix, Inc. | 87.61M | -2.25% | 120,984 | 41.00K |
| 402 | ONCY | Oncolytics Biotech Inc. | 87.49M | -1.69% | 338,246 | - |
| 403 | SPRO | Spero Therapeutics, Inc. | 87.31M | 1.25% | 237,632 | 103.78M |
| 404 | BRNS | Barinthus Biotherapeutics plc | 86.67M | -4.51% | 9,471 | 334.00K |
| 405 | ALVR | AlloVir, Inc. | 86.18M | -2.86% | 210,224 | - |
| 406 | SLS | SELLAS Life Sciences Group, Inc. | 84.90M | 7.30% | 1,449,154 | - |
| 407 | ATHA | Athira Pharma, Inc. | 84.70M | 0.45% | 135,651 | - |
| 408 | DTIL | Precision BioSciences, Inc. | 83.62M | 4.04% | 87,855 | 57.53M |
| 409 | HOOK | HOOKIPA Pharma Inc. | 82.94M | 4.15% | 375,225 | 53.55M |
| 410 | BNTC | Benitec Biopharma Inc. | 82.90M | 3.80% | 18,387 | 7.00K |
| 411 | PLX | Protalix BioTherapeutics, Inc. | 82.85M | -2.59% | 325,580 | 59.65M |
| 412 | IFRX | InflaRx N.V. | 82.44M | - | 82,392 | 107.75K |
| 413 | GRTS | Gritstone bio, Inc. | 81.43M | -1.48% | 1,473,418 | 15.65M |
| 414 | AFMD | Affimed N.V. | 81.31M | -0.38% | 23,942 | 9.19M |
| 415 | ASMB | Assembly Biosciences, Inc. | 80.55M | 3.62% | 17,666 | - |
| 416 | CUE | Cue Biopharma, Inc. | 79.78M | 5.81% | 263,502 | 7.02M |
| 417 | PASG | Passage Bio, Inc. | 78.86M | -3.40% | 70,306 | - |
| 418 | TIL | Instil Bio, Inc. | 78.70M | 2.10% | 5,309 | - |
| 419 | CGTX | Cognition Therapeutics, Inc. | 78.11M | -1.52% | 141,357 | - |
| 420 | CVM | CEL-SCI Corporation | 77.73M | 3.60% | 283,450 | - |
| 421 | PALI | Palisade Bio, Inc. | 77.39M | -0.16% | 37,807 | - |
| 422 | BTAI | BioXcel Therapeutics, Inc. | 77.31M | -3.29% | 729,357 | 1.76M |
| 423 | ATRA | Atara Biotherapeutics, Inc. | 77.07M | 5.79% | 991,911 | 34.70M |
| 424 | CRIS | Curis, Inc. | 76.62M | -17.14% | 84,832 | 9.81M |
| 425 | TARA | Protara Therapeutics, Inc. | 76.39M | 11.08% | 1,299,754 | - |
| 426 | TPST | Tempest Therapeutics, Inc. | 75.09M | -0.59% | 329,997 | - |
| 427 | LVTX | LAVA Therapeutics N.V. | 74.40M | -1.38% | 50,990 | 7.52M |
| 428 | SER | Serina Therapeutics Inc | 74.29M | -4.60% | 23,711 | 3.15M |
| 429 | JAGX | Jaguar Health, Inc. | 73.27M | -7.20% | 24,588,557 | 10.14M |
| 430 | CLGN | CollPlant Biotechnologies Ltd. | 73.19M | -4.43% | 5,364 | 10.96M |
| 431 | MNOV | MediciNova, Inc. | 73.08M | - | 3,267 | 1.00M |
| 432 | MRNS | Marinus Pharmaceuticals, Inc. | 73.06M | -0.75% | 1,071,646 | 28.29M |
| 433 | RLYB | Rallybio Corporation | 72.22M | 3.80% | 225,484 | - |
| 434 | CELU | Celularity Inc. | 72.10M | -8.52% | 92,113 | 14.79M |
| 435 | LABP | Landos Biopharma, Inc. | 69.92M | - | 11,683 | - |
| 436 | LTRN | Lantern Pharma Inc. | 68.10M | 2.26% | 85,737 | - |
| 437 | ANTX | AN2 Therapeutics, Inc. | 67.71M | -1.73% | 241,298 | - |
| 438 | TSBX | Turnstone Biologics Corp. | 67.39M | -3.83% | 79,104 | 19.31M |
| 439 | INTS | Intensity Therapeutics, Inc. | 66.23M | 10.00% | 44,169 | - |
| 440 | ALRN | Aileron Therapeutics, Inc. | 65.79M | - | 20,862 | - |
| 441 | CSBR | Champions Oncology, Inc. | 65.43M | 0.65% | 60,979 | 49.22M |
| 442 | MURA | Mural Oncology plc | 65.15M | -1.79% | 120,026 | - |
| 443 | TLSA | Tiziana Life Sciences Ltd | 64.94M | 12.85% | 184,624 | - |
| 444 | IKNA | Ikena Oncology, Inc. | 64.42M | 0.38% | 148,832 | 3.85M |
| 445 | VTVT | vTv Therapeutics Inc. | 62.96M | -0.38% | 2,064 | 1.00M |
| 446 | IMMX | Immix Biopharma, Inc. | 62.05M | 6.82% | 132,008 | - |
| 447 | AVRO | AVROBIO, Inc. | 61.50M | 6.20% | 573,940 | - |
| 448 | AEON | AEON Biopharma, Inc. | 61.28M | -3.07% | 105,735 | - |
| 449 | ANEB | Anebulo Pharmaceuticals, Inc. | 61.20M | -3.40% | 14,973 | - |
| 450 | THTX | Theratechnologies Inc. | 61.15M | 8.13% | 21,016 | 57.85M |
| 451 | ELDN | Eledon Pharmaceuticals, Inc. | 60.62M | 7.05% | 138,469 | - |
| 452 | OCEA | Ocean Biomedical, Inc. | 60.29M | 11.54% | 776,012 | - |
| 453 | CKPT | Checkpoint Therapeutics, Inc. | 60.07M | 4.49% | 260,859 | 68.00K |
| 454 | KRON | Kronos Bio, Inc. | 58.98M | -1.85% | 208,724 | 7.59M |
| 455 | GNTA | Genenta Science S.p.A. | 58.29M | -2.17% | 3,675 | - |
| 456 | CARM | Carisma Therapeutics, Inc. | 58.16M | -4.11% | 219,617 | 15.07M |
| 457 | CDTX | Cidara Therapeutics, Inc. | 57.98M | -2.90% | 20,326 | 63.91M |
| 458 | KZR | Kezar Life Sciences, Inc. | 56.22M | -2.18% | 424,650 | 7.00M |
| 459 | NTRB | Nutriband Inc. | 55.40M | 29.92% | 178,125 | 2.09M |
| 460 | EQ | Equillium, Inc. | 54.29M | - | 50,368 | 37.89M |
| 461 | EYEN | Eyenovia, Inc. | 54.02M | 28.28% | 2,824,927 | 3.79K |
| 462 | ABIO | ARCA biopharma, Inc. | 53.97M | 12.05% | 193,326 | - |
| 463 | RPHM | Reneo Pharmaceuticals, Inc. | 53.47M | -1.23% | 421,355 | - |
| 464 | BLRX | BioLineRx Ltd. | 51.93M | -3.71% | 454,148 | 4.80M |
| 465 | ALGS | Aligos Therapeutics, Inc. | 50.94M | -1.79% | 91,145 | 13.79M |
| 466 | OKYO | OKYO Pharma Limited | 49.86M | -2.70% | 10,912 | - |
| 467 | INAB | IN8bio, Inc. | 49.86M | 7.69% | 793,994 | - |
| 468 | CLNN | Clene Inc. | 49.14M | -0.39% | 216,108 | 620.00K |
| 469 | CTCX | Carmell Therapeutics Corporation | 48.30M | - | 14,252 | - |
| 470 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 47.74M | -6.30% | 406,708 | - |
| 471 | GANX | Gain Therapeutics, Inc. | 47.30M | 11.54% | 145,626 | - |
| 472 | MLEC | Moolec Science SA | 46.58M | -1.59% | 111,158 | 2.90M |
| 473 | IMRX | Immuneering Corporation | 46.56M | -1.88% | 105,733 | - |
| 474 | NXTC | NextCure, Inc. | 46.44M | 4.40% | 57,838 | - |
| 475 | DYAI | Dyadic International, Inc. | 45.90M | 5.37% | 103,813 | 2.26M |
| 476 | AADI | Aadi Bioscience, Inc. | 45.18M | -2.13% | 83,585 | 23.84M |
| 477 | OCUP | Ocuphire Pharma, Inc. | 44.30M | 1.76% | 125,141 | 19.01M |
| 478 | HCWB | HCW Biologics Inc. | 43.88M | 0.87% | 46,106 | 560.36K |
| 479 | CASI | CASI Pharmaceuticals, Inc. | 43.82M | 7.64% | 60,116 | 33.88M |
| 480 | MTNB | Matinas BioPharma Holdings, Inc. | 43.29M | -1.76% | 963,961 | - |
| 481 | CARA | Cara Therapeutics, Inc. | 41.54M | 5.02% | 494,368 | 16.94M |
| 482 | XLO | Xilio Therapeutics, Inc. | 41.34M | 2.84% | 117,414 | - |
| 483 | UNCY | Unicycive Therapeutics, Inc. | 40.61M | -0.92% | 69,869 | - |
| 484 | LEXX | Lexaria Bioscience Corp. | 39.69M | - | 174,378 | 386.00K |
| 485 | ESLA | Estrella Immunopharma, Inc. | 39.54M | 0.93% | 8,097 | - |
| 486 | QNCX | Quince Therapeutics, Inc. | 39.24M | -1.03% | 76,232 | - |
| 487 | MAIA | MAIA Biotechnology, Inc. | 39.11M | 1.06% | 87,368 | - |
| 488 | VYNE | VYNE Therapeutics Inc. | 38.91M | -2.77% | 31,461 | 423.00K |
| 489 | IGC | IGC Pharma Inc | 38.28M | 3.47% | 284,032 | 1.22M |
| 490 | ICCC | ImmuCell Corporation | 38.18M | -11.27% | 67,022 | 21.28M |
| 491 | ACHL | Achilles Therapeutics plc | 37.80M | - | 12,533 | - |
| 492 | SNSE | Sensei Biotherapeutics, Inc. | 37.37M | -1.32% | 85,044 | - |
| 493 | MRKR | Marker Therapeutics, Inc. | 37.17M | 1.96% | 15,159 | 3.31M |
| 494 | SABS | SAB Biotherapeutics, Inc. | 36.90M | -2.65% | 1,800 | 2.24M |
| 495 | DARE | Daré Bioscience, Inc. | 36.21M | 14.29% | 2,109,973 | 2.82M |
| 496 | INKT | MiNK Therapeutics, Inc. | 36.09M | -7.14% | 560,181 | - |
| 497 | ACXP | Acurx Pharmaceuticals, Inc. | 35.60M | 7.66% | 169,629 | - |
| 498 | EVGN | Evogene Ltd. | 34.53M | -2.47% | 69,287 | 5.64M |
| 499 | PMN | ProMIS Neurosciences, Inc. | 34.13M | -8.16% | 8,102 | - |
| 500 | NRXP | NRx Pharmaceuticals, Inc. | 34.09M | 1.57% | 181,414 | - |
| 501 | FBIO | Fortress Biotech, Inc. | 33.47M | -1.14% | 100,265 | 84.51M |
| 502 | PTN | Palatin Technologies, Inc. | 33.40M | -14.11% | 366,744 | 7.10M |
| 503 | RNXT | RenovoRx, Inc. | 33.29M | -2.78% | 18,540 | - |
| 504 | BCLI | Brainstorm Cell Therapeutics Inc. | 33.08M | -3.22% | 465,241 | - |
| 505 | VIRX | Viracta Therapeutics, Inc. | 32.99M | 4.74% | 141,349 | - |
| 506 | SPRB | Spruce Biosciences, Inc. | 32.92M | -3.01% | 732,061 | 10.13M |
| 507 | PLUR | Pluri Inc. | 32.82M | -8.13% | 7,315 | 341.00K |
| 508 | SRZN | Surrozen, Inc. | 32.48M | -1.30% | 44,038 | - |
| 509 | BOLT | Bolt Biotherapeutics, Inc. | 31.65M | -37.12% | 3,775,896 | 11.32M |
| 510 | APRE | Aprea Therapeutics, Inc. | 31.50M | -1.69% | 11,330 | 963.80K |
| 511 | APLM | Apollomics, Inc. | 30.72M | 0.97% | 108,114 | - |
| 512 | IPA | ImmunoPrecise Antibodies Ltd. | 30.22M | - | 89,871 | 17.67M |
| 513 | LPCN | Lipocine Inc. | 30.06M | 5.05% | 27,851 | 4.71M |
| 514 | BIVI | BioVie Inc. | 27.18M | -0.82% | 383,566 | - |
| 515 | ENLV | Enlivex Therapeutics Ltd. | 26.40M | -2.07% | 71,547 | - |
| 516 | ONCT | Oncternal Therapeutics, Inc. | 26.16M | 4.25% | 6,660 | 1.15M |
| 517 | BCTX | BriaCell Therapeutics Corp. | 26.05M | -20.38% | 301,113 | - |
| 518 | GDTC | CytoMed Therapeutics Limited | 26.02M | 8.94% | 709 | - |
| 519 | ICU | SeaStar Medical Holding Corporation | 25.76M | -11.87% | 1,541,295 | - |
| 520 | UBX | Unity Biotechnology, Inc. | 25.68M | - | 48,767 | - |
| 521 | BIOR | Biora Therapeutics, Inc. | 25.66M | -3.10% | 313,968 | 4.00K |
| 522 | NKGN | NKGen Biotech, Inc. | 25.64M | - | 46,711 | - |
| 523 | ACST | Acasti Pharma Inc. | 25.38M | -2.70% | 27,917 | - |
| 524 | ITRM | Iterum Therapeutics plc | 24.67M | 0.67% | 51,674 | - |
| 525 | APM | Aptorum Group Limited | 24.35M | 1.85% | 9,562 | 431.38K |
| 526 | LSTA | Lisata Therapeutics, Inc. | 23.63M | - | 3,836 | - |
| 527 | FBRX | Forte Biosciences, Inc. | 23.32M | -5.59% | 25,906 | - |
| 528 | LYRA | Lyra Therapeutics, Inc. | 21.69M | -4.35% | 2,349,377 | 1.68M |
| 529 | COCP | Cocrystal Pharma, Inc. | 21.36M | 11.11% | 69,637 | - |
| 530 | NNVC | NanoViricides, Inc. | 21.20M | -20.35% | 343,057 | - |
| 531 | NRBO | NeuroBo Pharmaceuticals, Inc. | 20.80M | 0.97% | 13,485 | - |
| 532 | NRSN | NeuroSense Therapeutics Ltd. | 20.77M | 2.68% | 61,850 | - |
| 533 | MEIP | MEI Pharma, Inc. | 20.69M | -1.74% | 29,032 | 66.75M |
| 534 | VINC | Vincerx Pharma, Inc. | 20.50M | -2.18% | 294,930 | - |
| 535 | AIM | AIM ImmunoTech Inc. | 20.33M | 3.80% | 172,855 | 202.00K |
| 536 | EVAX | Evaxion Biotech A/S | 20.18M | 1.85% | 12,594 | 73.00K |
| 537 | SYBX | Synlogic, Inc. | 20.00M | -1.71% | 131,499 | 3.21M |
| 538 | SLGL | Sol-Gel Technologies Ltd. | 19.49M | -0.78% | 44,639 | 1.55M |
| 539 | ORGS | Orgenesis Inc. | 19.45M | -6.45% | 14,815 | 530.00K |
| 540 | NRXS | NeurAxis, Inc. | 19.43M | -2.48% | 18,390 | 2.46M |
| 541 | INDP | Indaptus Therapeutics, Inc. | 19.38M | 11.42% | 20,718 | - |
| 542 | APTO | Aptose Biosciences Inc. | 19.18M | -4.07% | 42,831 | - |
| 543 | PHGE | BiomX Inc. | 19.08M | 2.60% | 43,940 | - |
| 544 | TCRT | Alaunos Therapeutics, Inc. | 19.05M | -7.39% | 19,926 | 5.00K |
| 545 | KALA | Kala Pharmaceuticals, Inc. | 19.03M | -3.30% | 3,523 | - |
| 546 | VBIV | VBI Vaccines Inc. | 18.84M | 3.16% | 249,689 | 8.68M |
| 547 | CDIO | Cardio Diagnostics Holdings, Inc. | 18.28M | 4.09% | 466,503 | 17.07K |
| 548 | LUMO | Lumos Pharma, Inc. | 18.18M | -12.16% | 137,938 | 2.05M |
| 549 | NERV | Minerva Neurosciences, Inc. | 18.01M | 1.21% | 10,622 | - |
| 550 | ATHE | Alterity Therapeutics Limited | 17.83M | -0.72% | 6,326 | - |
| 551 | PMCB | PharmaCyte Biotech, Inc. | 17.67M | -3.24% | 10,455 | - |
| 552 | GLYC | GlycoMimetics, Inc. | 17.40M | -2.17% | 1,199,810 | 10.00K |
| 553 | SNTI | Senti Biosciences, Inc. | 17.29M | -6.12% | 58,733 | 1.28M |
| 554 | GLTO | Galecto, Inc. | 17.14M | -7.03% | 422,541 | - |
| 555 | TRAW | Traws Pharma, Inc. | 16.63M | 1.12% | 27,962 | 226.00K |
| 556 | IBIO | iBio, Inc. | 16.19M | - | 87,102 | 50.00K |
| 557 | XTLB | XTL Biopharmaceuticals Ltd. | 15.77M | 2.25% | 17,684 | - |
| 558 | TNXP | Tonix Pharmaceuticals Holding Corp. | 15.43M | 1.44% | 964,338 | 10.25M |
| 559 | EDSA | Edesa Biotech, Inc. | 14.50M | -0.44% | 35,766 | - |
| 560 | ADXN | Addex Therapeutics Ltd | 14.26M | -2.22% | 14,001 | 1.96M |
| 561 | PIRS | Pieris Pharmaceuticals, Inc. | 14.06M | 2.29% | 8,246 | 42.81M |
| 562 | KPRX | Kiora Pharmaceuticals, Inc. | 13.52M | 2.98% | 46,762 | 16.00M |
| 563 | ONVO | Organovo Holdings, Inc. | 13.38M | 4.04% | 361,895 | 242.00K |
| 564 | IMNN | Imunon, Inc. | 13.25M | 4.09% | 30,260 | - |
| 565 | IMRN | Immuron Limited | 13.17M | -0.86% | 20,105 | 2.43M |
| 566 | PPBT | Purple Biotech Ltd. | 13.12M | -4.94% | 62,620 | - |
| 567 | IKT | Inhibikase Therapeutics, Inc. | 12.89M | 30.92% | 564,724 | 260.50K |
| 568 | COEP | Coeptis Therapeutics, Inc. | 12.81M | -1.79% | 62,270 | - |
| 569 | DOMH | Dominari Holdings Inc. | 12.40M | 2.68% | 4,009 | 3.41M |
| 570 | CHRO | Chromocell Therapeutics Corp | 12.40M | -6.45% | 22,010 | - |
| 571 | CMMB | Chemomab Therapeutics Ltd. | 12.40M | -0.91% | 55,065 | - |
| 572 | ERNA | Eterna Therapeutics Inc. | 11.47M | -0.84% | 23,509 | 115.00K |
| 573 | CLDI | Calidi Biotherapeutics, Inc. | 11.44M | 1.86% | 165,627 | - |
| 574 | ABVC | ABVC BioPharma, Inc. | 11.41M | - | 320,077 | 152.43K |
| 575 | ELAB | Elevai Labs, Inc. | 11.25M | -2.61% | 69,407 | 1.71M |
| 576 | MBRX | Moleculin Biotech, Inc. | 11.14M | - | 7,718 | - |
| 577 | AVTX | Avalo Therapeutics, Inc. | 10.74M | -1.98% | 30,879 | 1.45M |
| 578 | BCDA | BioCardia, Inc. | 10.74M | 0.98% | 90,322 | 468.00K |
| 579 | CANF | Can-Fite BioPharma Ltd. | 10.61M | 2.35% | 6,646 | 743.00K |
| 580 | AEZS | Aeterna Zentaris Inc. | 10.49M | 2.02% | 16,952 | 4.50M |
| 581 | MNPR | Monopar Therapeutics Inc. | 10.46M | -7.27% | 109,092 | - |
| 582 | GRTX | Galera Therapeutics, Inc. | 10.33M | 8.51% | 403,242 | - |
| 583 | FRES | Fresh2 Group Ltd | 10.23M | 4.10% | 6,183 | 2.35M |
| 584 | PSTV | Plus Therapeutics, Inc. | 9.92M | 6.91% | 179,495 | 4.91M |
| 585 | BNOX | Bionomics Limited | 9.84M | -4.17% | 38,878 | 15.00K |
| 586 | NTBL | Notable Labs, Ltd. | 9.74M | -1.82% | 67,313 | 310.00K |
| 587 | AKTX | Akari Therapeutics, Plc | 9.66M | 1.71% | 6,576 | - |
| 588 | MTEM | Molecular Templates, Inc. | 9.55M | -2.68% | 55,783 | 57.31M |
| 589 | EFTR | eFFECTOR Therapeutics, Inc. | 9.31M | -1.00% | 111,103 | - |
| 590 | BRTX | BioRestorative Therapies, Inc. | 9.27M | 0.74% | 126,001 | 145.80K |
| 591 | LGVN | Longeveron Inc. | 8.48M | -3.60% | 489,510 | 978.00K |
| 592 | VCNX | Vaccinex, Inc. | 8.01M | -1.23% | 4,361 | 570.00K |
| 593 | NCNA | NuCana plc | 7.92M | 1.32% | 24,948 | - |
| 594 | PYPD | PolyPid Ltd. | 7.84M | 8.97% | 1,416 | - |
| 595 | VIRI | Virios Therapeutics, Inc. | 7.83M | 14.44% | 154,875 | - |
| 596 | CYCN | Cyclerion Therapeutics, Inc. | 7.81M | -4.00% | 276 | - |
| 597 | TRVN | Trevena, Inc. | 7.70M | 0.99% | 49,674 | 3.13M |
| 598 | OGEN | Oragenics, Inc. | 7.34M | -2.42% | 70,577 | 37.65K |
| 599 | KTRA | Kintara Therapeutics, Inc. | 7.25M | 2.42% | 3,757,207 | - |
| 600 | CVKD | Cadrenal Therapeutics, Inc. | 7.10M | 1.45% | 123,163 | - |
| 601 | ASLN | ASLAN Pharmaceuticals Limited | 7.04M | - | 133,362 | 12.00M |
| 602 | TENX | Tenax Therapeutics, Inc. | 7.03M | 3.46% | 23,654 | - |
| 603 | KTTA | Pasithea Therapeutics Corp. | 6.93M | - | 1,090 | - |
| 604 | KZIA | Kazia Therapeutics Limited | 6.79M | -1.21% | 201,753 | 15.65K |
| 605 | PULM | Pulmatrix, Inc. | 6.68M | 1.67% | 11,529 | 11.68M |
| 606 | TOVX | Theriva Biologics, Inc. | 6.41M | -0.80% | 47,608 | - |
| 607 | HEPA | Hepion Pharmaceuticals, Inc. | 6.29M | -12.40% | 79,798 | - |
| 608 | TFFP | TFF Pharmaceuticals, Inc. | 6.23M | 13.81% | 50,154 | 885.72K |
| 609 | PTIX | Protagenic Therapeutics, Inc. | 6.16M | 6.03% | 4,819 | - |
| 610 | ENVB | Enveric Biosciences, Inc. | 6.11M | -3.96% | 181,082 | - |
| 611 | XBIO | Xenetic Biosciences, Inc. | 6.09M | 0.15% | 1,657 | 2.44M |
| 612 | TTNP | Titan Pharmaceuticals, Inc. | 5.99M | -1.50% | 846 | 184.00K |
| 613 | CELZ | Creative Medical Technology Holdings, Inc. | 5.97M | -1.38% | 1,681 | 9.00K |
| 614 | LIPO | Lipella Pharmaceuticals Inc. | 5.80M | 0.01% | 14,631 | 477.45K |
| 615 | NLSP | NLS Pharmaceutics AG | 5.78M | -0.68% | 49,413 | - |
| 616 | PCSA | Processa Pharmaceuticals, Inc. | 5.77M | -7.34% | 108,079 | - |
| 617 | ADIL | Adial Pharmaceuticals, Inc. | 5.76M | -1.39% | 154,831 | - |
| 618 | SNGX | Soligenix, Inc. | 5.74M | -7.34% | 449,363 | 699.21K |
| 619 | FWBI | First Wave BioPharma, Inc. | 5.73M | -5.03% | 44,522 | - |
| 620 | HOTH | Hoth Therapeutics, Inc. | 5.67M | 0.83% | 38,573 | - |
| 621 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.57M | -1.10% | 7,458 | 92.73K |
| 622 | KA | Kineta, Inc. | 5.43M | -12.29% | 131,729 | 5.44M |
| 623 | RNAZ | TransCode Therapeutics, Inc. | 5.30M | 10.48% | 2,448,852 | - |
| 624 | GNPX | Genprex, Inc. | 5.26M | -3.77% | 44,940 | - |
| 625 | SILO | Silo Pharma, Inc. | 5.15M | -3.05% | 14,451 | 72.10K |
| 626 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.15M | -13.26% | 62,187 | - |
| 627 | SNPX | Synaptogenix, Inc. | 5.11M | 4.57% | 89,142 | - |
| 628 | AZTR | Azitra, Inc. | 5.07M | 0.17% | 628,603 | 572.70K |
| 629 | PRTG | Portage Biotech Inc. | 5.06M | -3.83% | 61,170 | - |
| 630 | XRTX | XORTX Therapeutics Inc. | 4.98M | -1.19% | 12,546 | - |
| 631 | SEEL | Seelos Therapeutics, Inc. | 4.82M | 19.72% | 1,954,274 | 1.97M |
| 632 | NEXI | NexImmune, Inc. | 4.75M | -0.72% | 1,702 | - |
| 633 | DRUG | Bright Minds Biosciences Inc. | 4.69M | 5.71% | 24,217 | - |
| 634 | ENSC | Ensysce Biosciences, Inc. | 4.64M | 8.72% | 544,837 | - |
| 635 | MYMD | MyMD Pharmaceuticals, Inc. | 4.53M | -9.29% | 24,577 | - |
| 636 | XCUR | Exicure, Inc. | 4.32M | -2.06% | 4,922 | 23.79M |
| 637 | ARTL | Artelo Biosciences, Inc. | 4.26M | -4.35% | 8,119 | - |
| 638 | THAR | Tharimmune, Inc. | 4.26M | 0.80% | 223,018 | - |
| 639 | ALZN | Alzamend Neuro, Inc. | 4.26M | 2.16% | 68,459 | - |
| 640 | GTBP | GT Biopharma, Inc. | 4.21M | -2.24% | 9,009 | - |
| 641 | CMND | Clearmind Medicine Inc. | 4.06M | -0.78% | 73,572 | - |
| 642 | ADTX | Aditxt, Inc. | 4.02M | -5.91% | 24,236 | 645.18K |
| 643 | GOVX | GeoVax Labs, Inc. | 3.97M | 3.24% | 73,479 | - |
| 644 | NBY | NovaBay Pharmaceuticals, Inc. | 3.95M | 24.40% | 10,641,578 | 14.23M |
| 645 | ZVSA | ZyVersa Therapeutics, Inc. | 3.75M | -7.32% | 58,450 | - |
| 646 | TCON | TRACON Pharmaceuticals, Inc. | 3.69M | -18.18% | 200,336 | 12.15M |
| 647 | PHIO | Phio Pharmaceuticals Corp. | 3.67M | 8.75% | 103,683 | - |
| 648 | TCBP | TC Biopharm (Holdings) Plc | 3.58M | -2.61% | 331,918 | - |
| 649 | BPTH | Bio-Path Holdings, Inc. | 3.51M | -13.18% | 134,366 | - |
| 650 | MBIO | Mustang Bio, Inc. | 3.46M | 0.11% | 78,309 | - |
| 651 | CYTO | Altamira Therapeutics Ltd. | 3.43M | 6.12% | 55,078 | - |
| 652 | FNCH | Finch Therapeutics Group, Inc. | 3.37M | 6.19% | 18,665 | - |
| 653 | APVO | Aptevo Therapeutics Inc. | 3.30M | -2.42% | 129,204 | - |
| 654 | CYCC | Cyclacel Pharmaceuticals, Inc. | 3.22M | -14.08% | 163,000 | 449.00K |
| 655 | REVB | Revelation Biosciences, Inc. | 3.18M | 4.84% | 21,203 | - |
| 656 | CING | Cingulate Inc. | 3.14M | -2.48% | 47,706 | - |
| 657 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.95M | 0.78% | 25,790 | - |
| 658 | SPRC | SciSparc Ltd. | 2.94M | -4.72% | 109,499 | 2.88M |
| 659 | SCPX | Scorpius Holdings, Inc. | 2.80M | 1.17% | 9,991,931 | 6.99M |
| 660 | VRPX | Virpax Pharmaceuticals, Inc. | 2.75M | -65.64% | 2,645,096 | - |
| 661 | SCNI | Scinai Immunotherapeutics Ltd. | 2.64M | - | 7,885 | - |
| 662 | ONCO | Onconetix, Inc. | 2.49M | 1.35% | 96,148 | 58.47K |
| 663 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.47M | -2.47% | 537,554 | 253.57K |
| 664 | WINT | Windtree Therapeutics, Inc. | 2.35M | 13.18% | 55,543 | - |
| 665 | GLMD | Galmed Pharmaceuticals Ltd. | 2.31M | -4.90% | 41,512 | - |
| 666 | DRMA | Dermata Therapeutics, Inc. | 2.20M | -4.16% | 103,355 | - |
| 667 | SLRX | Salarius Pharmaceuticals, Inc. | 2.19M | -3.99% | 14,581 | - |
| 668 | ATXI | Avenue Therapeutics, Inc. | 2.17M | -4.95% | 47,266 | - |
| 669 | CNSP | CNS Pharmaceuticals, Inc. | 2.12M | -5.61% | 182,918 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 2.10M | 5.61% | 135,130 | - |
| 671 | VRAX | Virax Biolabs Group Limited | 1.85M | 0.13% | 8,967 | 79.30K |
| 672 | INM | InMed Pharmaceuticals Inc. | 1.66M | 2.25% | 97,878 | 5.63M |
| 673 | ATNF | 180 Life Sciences Corp. | 1.65M | -2.00% | 12,666 | - |
| 674 | ALLR | Allarity Therapeutics, Inc. | 1.62M | -13.75% | 5,454,181 | - |
| 675 | GRI | GRI Bio, Inc. | 1.51M | -1.26% | 107,083 | - |
| 676 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 89,703 | - |
| 677 | BDRX | Biodexa Pharmaceuticals Plc | 267.26K | 2.73% | 194,349 | 482.28K |